Yunyan Wan
Papers
1
Total Citations
2
H-Index
1
About
Dr. Yunyan Wan is a leading surgical oncologist whose research focuses on optimizing minimally invasive surgical approaches for hepatocellular carcinoma (HCC), particularly through comparative effectiveness studies. Her most notable contribution is a landmark 2025 nationwide cohort study examining clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection for BCLC stage 0/A HCC. This work directly addresses critical debates in hepatobiliary surgery by providing real-world evidence comparing these three approaches. With 2 citations already, this study is gaining rapid attention for its comprehensive analysis of both clinical efficacy and cost-effectiveness—a crucial consideration for healthcare systems adopting robotic surgery. Dr. Wan’s research bridges the gap between surgical innovation and practical implementation, helping surgeons and hospitals make evidence-based decisions about surgical approaches for early-stage liver cancer. Her work represents an important step toward personalized surgical care, demonstrating that while robotic and laparoscopic techniques offer advantages in recovery, their economic impact must be carefully weighed against open surgery outcomes.
Research Focus
Key Achievements
Top Papers
- 1